Relopduo has officially entered the Indian market. The launch marks another step in strengthening cancer treatment options.
MedTech Innovation is accelerating in India as Tata Elxsi partners with Sree Chitra Tirunal Institute for Medical Sciences and Technology
Onco-derma therapy is transforming cancer care in India with the launch of Relopduo, a fixed-dose combination of nivolumab and relatlimab by Bristol Myers Squibb
Naidu Launches Sanjeevani with AI-Driven Healthcare Vision as Andhra Pradesh moves to modernize public healthcare.
Congo Ebola outbreak has entered a more critical phase after confirmed infections crossed 3,000. The latest figures show the Congo Ebola outbreak continues to spread despite ongoing response efforts.
India’s pharmaceutical and healthcare sector continues to evolve rapidly, driven by regulatory shifts, investments, technological advancements, and public health initiatives
The Top News from the pharmaceutical sector this week reflects a rapidly evolving landscape driven by innovation, regulation, and global health priorities
The pharmaceutical industry continues to evolve, driven by regulatory shifts, legal battles, clinical trial outcomes, strategic partnerships, and strong commercial performance
India’s rapid healthcare expansion highlights the urgent need to ensure that growth translates into making healthcare affordable for a larger population
India is strengthening its healthcare ecosystem through new institutional collaborations to accelerate Medical Research in India, with a clear focus on improving patient-centric outcomes through data-backed and evidence-based practices
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")